JAJohanneke F. de Rijk-Van Andel

Johanneke F. de Rijk-Van Andel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Johanneke F. de Rijk-Van Andel has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Ron Allan Wevers

    Translational Metabolic Laboratory, Department Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands

    2 shared publications
  • B. Geurtz

    From the Department of Neurology (Dr. de Rijk–van Andel), Ignatius Hospital Breda; Department of Child Neurology (Dr. Gabreëls), Laboratory of Pediatrics and Neurology (Drs. van den Heuvel and Wevers, and B. Geurtz and G.C.H. Steenbergen–Spanjers), and Department of Metabolic Diseases (Dr. Smeitink), University Medical Centre Nijmegen, the Netherlands

    1 shared publication
  • Bernadette Luiten

    Laboratory of Pediatrics and Neurology, University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands B., Tel.: +31 24 3617983 or +31 24 3616872, Fax: 31 24 3616428

    1 shared publication
  • F. J.M. Gabreëls

    From the Department of Neurology (Dr. de Rijk–van Andel), Ignatius Hospital Breda; Department of Child Neurology (Dr. Gabreëls), Laboratory of Pediatrics and Neurology (Drs. van den Heuvel and Wevers, and B. Geurtz and G.C.H. Steenbergen–Spanjers), and Department of Metabolic Diseases (Dr. Smeitink), University Medical Centre Nijmegen, the Netherlands

    1 shared publication
  • G. C.H. Steenbergen–Spanjers

    From the Department of Neurology (Dr. de Rijk–van Andel), Ignatius Hospital Breda; Department of Child Neurology (Dr. Gabreëls), Laboratory of Pediatrics and Neurology (Drs. van den Heuvel and Wevers, and B. Geurtz and G.C.H. Steenbergen–Spanjers), and Department of Metabolic Diseases (Dr. Smeitink), University Medical Centre Nijmegen, the Netherlands

    1 shared publication
  • Gerry C. H. Steenbergen-Spanjers

    Laboratory of Pediatrics and Neurology, University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands B., Tel.: +31 24 3617983 or +31 24 3616872, Fax: 31 24 3616428

    1 shared publication

Latest Publications

  • l -dopa–responsive infantile hypokinetic rigid parkinsonism due to tyrosine hydroxylase deficiency

    by J. F. de Rijk–Van Andel, F. J.M. Gabreëls, B. Geurtz, G. C.H. Steenbergen–Spanjers, L. P.W.J. van Den Heuvel, J. A.M. Smeitink, R. A. Wevers

    Article abstract Tyrosine hydroxylase deficiency was confirmed biochemically and genetically in four unrelated Dutch patients. The patients have a hypokinetic-rigid parkinsonian syndrome with symptoms in early infancy (3 to 6 months of age). Only sporadic dystonic movements were seen. There was no diurnal fluctuation. All patients showed a rapid favorable response to low-dose l-dopa/carbidopa treatment. Motor performance improved but did not fully normalize. The patients have mild mental retardation.


  • A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population

    by L. P. W. J. van Den Heuvel, Bernadette Luiten, J. A. M. Smeitink, Johanneke F. de Rijk-Van Andel, Keith Hyland, Gerry C. H. Steenbergen-Spanjers, R. J. T. Janssen, R. A. Wevers

    This report concerns one new mutation in the tyrosine hydroxylase (TH) gene in three patients originating from three unrelated Dutch families with autosomal recessive L-DOPA-responsive dystonia (DRD). In this study, all exons of the TH gene were amplified by the polymerase chain reaction and subjected to analyses by single-strand conformation polymorphism. An aberrant migration pattern was observed for exon 6 of the TH gene in all patients. Direct sequencing of the coding region of exon 6 revealed the presence of one novel missense mutation. An a698g transition resulted in the substitution of the evolutionary conserved arginine 233 by a histidine (R233H). All patients were homozygous for the mutation. This new mutation in the TH gene was confirmed by restriction enzyme analysis with the restriction enzyme HhaI. Thus, a high proportion of defective TH alleles may be R233H in The Netherlands.